Malignant neoplasm of lung
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The results of this meta-analysis based on all the studies showed no significant association between ACE I/D gene polymorphism and lung cancer risk (DD vs II: OR = 1.18, 95% CI = 0.68-2.04; DI vs II: OR = 0.93, 95% CI = 0.56-1.53; DD+DI vs II: OR = 1.01, 95% CI = 0.68-1.50; DD vs II+DD: OR =1.11, 95% CI = 0.73-1.71).
|
25354524 |
2015 |
Malignant neoplasm of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
In the present study, we have evaluated the roles of CYP1A1 and dihydrodiol dehydrogenase (DDH) in the formation of benzo[a]pyrene (BaP) DNA adducts in various lung cancer cell lines.
|
17163506 |
2007 |
Carcinoma of lung
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The results of this meta-analysis based on all the studies showed no significant association between ACE I/D gene polymorphism and lung cancer risk (DD vs II: OR = 1.18, 95% CI = 0.68-2.04; DI vs II: OR = 0.93, 95% CI = 0.56-1.53; DD+DI vs II: OR = 1.01, 95% CI = 0.68-1.50; DD vs II+DD: OR =1.11, 95% CI = 0.73-1.71).
|
25354524 |
2015 |
Carcinoma of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
In the present study, we have evaluated the roles of CYP1A1 and dihydrodiol dehydrogenase (DDH) in the formation of benzo[a]pyrene (BaP) DNA adducts in various lung cancer cell lines.
|
17163506 |
2007 |
Primary malignant neoplasm of lung
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The results of this meta-analysis based on all the studies showed no significant association between ACE I/D gene polymorphism and lung cancer risk (DD vs II: OR = 1.18, 95% CI = 0.68-2.04; DI vs II: OR = 0.93, 95% CI = 0.56-1.53; DD+DI vs II: OR = 1.01, 95% CI = 0.68-1.50; DD vs II+DD: OR =1.11, 95% CI = 0.73-1.71).
|
25354524 |
2015 |
Primary malignant neoplasm of lung
|
0.020 |
Biomarker
|
disease |
BEFREE |
In the present study, we have evaluated the roles of CYP1A1 and dihydrodiol dehydrogenase (DDH) in the formation of benzo[a]pyrene (BaP) DNA adducts in various lung cancer cell lines.
|
17163506 |
2007 |
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas.
|
17009030 |
2007 |
Non-Small Cell Lung Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer.
|
11289154 |
2001 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
The aim of this case-control study is to investigate if II-DD-SG is superior to medical treatment in T2DM obese patients.
|
30225603 |
2019 |
Leukemia, Radiation-Induced
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, the levels of ATF-1 mRNA in uninfected and radiation leukemia virus-infected thymocytes parallel those of H-2Dd mRNA, and therefore, it is suggested that ATF-1 up-regulates the transcription of the H-2Dd gene after radiation leukemia virus infection of thymocytes.
|
9188502 |
1997 |
Virus Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
In addition, the levels of ATF-1 mRNA in uninfected and radiation leukemia virus-infected thymocytes parallel those of H-2Dd mRNA, and therefore, it is suggested that ATF-1 up-regulates the transcription of the H-2Dd gene after radiation leukemia virus infection of thymocytes.
|
9188502 |
1997 |
Left Ventricular Hypertrophy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Of the 447 study subjects (age 71 ± 5, 47% men) with SBHF, 13% had LVH, 32% impaired GLS, and 65% ≥grade I DD (10% ≥grade II DD).Forty were lost to follow-up.
|
29154431 |
2017 |
Germ cell tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have previously demonstrated that overexpression of dihydrodiol dehydrogenase isoform 1 (DDH1) or DDH2 leads to the induction of drug resistance to platinum based drugs in human ovarian, lung, cervical and germ cell tumor cell lines.
|
17661040 |
2008 |
Childhood Germ Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have previously demonstrated that overexpression of dihydrodiol dehydrogenase isoform 1 (DDH1) or DDH2 leads to the induction of drug resistance to platinum based drugs in human ovarian, lung, cervical and germ cell tumor cell lines.
|
17661040 |
2008 |
Squamous cell carcinoma of esophagus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Inverse expression of dihydrodiol dehydrogenase and glutathione-S-transferase in patients with esophageal squamous cell carcinoma.
|
15197778 |
2004 |
Human papilloma virus infection
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
To determine the association of human papillomavirus (HPV) infection with the expression of dihydrodiol dehydrogenase (DDH) in uterine cervical cancer (UCC).
|
16427687 |
2006 |
Breast Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In this study, rat liver 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (AKR1C9) was stably transfected into human breast carcinoma (MCF-7) cells, which represent a null-environment for AKR expression, to detect the formation of PAH o-quinones in a cellular context and the cellular consequences of o-quinone formation.
|
11453732 |
2001 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.
|
12579257 |
2003 |
Adult Germ Cell Tumor
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have previously demonstrated that overexpression of dihydrodiol dehydrogenase isoform 1 (DDH1) or DDH2 leads to the induction of drug resistance to platinum based drugs in human ovarian, lung, cervical and germ cell tumor cell lines.
|
17661040 |
2008 |
cervical cancer
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer.
|
16427687 |
2006 |
Dupuytren's Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We noted a statistically significantly higher prevalence of the variants of the dihydrodiol dehydrogenase gene (rs2270941 and rs11666105) in the group with a positive familial history of Dupuytren's disease, in comparison with the group with a negative familial history.
|
23303836 |
2013 |
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.
|
21716162 |
2011 |
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.
|
21716162 |
2011 |
Stomach Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Overexpression of dihydrodiol dehydrogenase as a prognostic marker in resected gastric cancer patients.
|
18600452 |
2009 |